Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Revolutionizing cell cultures transport
The biotech InSphero has developed revolutionary new transport technology. It is thereby enabling live cell cultures to be safely transported to laboratories worldwide.
Fotokite to supply German fire services
Brandschutztechnik Schlichtiger GmbH intends to offer the aerial situational awareness system created by Zurich start-up Fotokite to German fire services. To this end, the two companies have just agreed on a strategic partnership.
DeepCode well received by developers
Zurich – A total of four million developers have already agreed to have their coding reviewed by DeepCode. The software developed by the start-up is based on Artificial Intelligence (AI) and can be used to uncover security vulnerabilities, for example. DeepCode also played a role in the development of Switzerland’s Covid-19 app.
Bitcoin Suisse secures CHF 45 million
The crypto exchange Bitcoin Suisse has raised a total of 45 million Swiss francs as part of a Series A financing round. It intends to use the fresh capital to offer new services and secure international growth. The next aim is to become a unicorn.
Messengers for cell communication discovered at ETH
Zurich – Researchers working at the Swiss Federal Institute of Technology in Zurich (ETH) have discovered how genes and viruses in a cell of origin can be silenced in far-off tissues and organs as well. The research group identified the mobile messengers for this protective mechanism seen in plants and animals.
Olympus and Cytosurge agree partnership
Opfikon ZH - Olympus has agreed a further partnership with the ETH spin-off Cytosurge. The objective of this collaboration is to market single-cell and CRISPR gene manipulation solutions in the Americas. The two partners have been also been working together for a year in the field of development.
Investors won over by artificial muscles
MyoSwiss has raised a total of 2.2 million Swiss francs as part of a financing round. The spin-off from ETH Zurich is developing a suit of artificial muscles aimed at improving the quality of life for people living with disabilities that restrict their mobility.
Biognosys cooperating with Boehringer Ingelheim
Schlieren ZH – The biotech firm Biognosys has agreed a collaboration with the pharmaceutical company Boehringer Ingelheim. Biognosys will bring its expertise in the field of proteomics to the table with the aim of optimizing drug development processes at Boehringer Ingelheim.
LafargeHolcim rolling out green concrete worldwide
Zug – LafargeHolcim has launched a range of green high-performance concrete. Following the successful introduction in Europe, it will now be brought to markets in North and Latin America. The new product will advance the transition towards circular construction.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space